Security · CUSIP 55414P702
MABVAX THERAPEUTICS
EQUITIES · institutional ownership from 13F filings
13F holders
1
Shares held
23
Value held
$0
New / sold out
1 / 0
Added / reduced
0 / 0
net +23 shares
13F holders by quarter
Net shares bought by existing holders
Top holders · Q2 2022
| Manager | Shares | Value | % of portfolio |
|---|---|---|---|
| Eagle Bay Advisors LLC | 23 | $0 | 0.00% |
Biggest buyers
| Manager | Change | Shares change | Change % |
|---|---|---|---|
| Eagle Bay Advisors LLC | New | +23 | – |
Biggest sellers
Nothing to show.